Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06565520 · ClinicalTrials.gov registry record · NA

Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain

A NA study of Patellofemoral Pain Syndrome, sponsored by University of Nevada, Las Vegas.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06565520: Recruiting NA study of Patellofemoral Pain Syndrome, sponsored by University of Nevada, Las Vegas.

NCT06565520 is a NA study of Patellofemoral Pain Syndrome that is actively recruiting participants, run by University of Nevada, Las Vegas. The registered enrollment target is 50 participants, below the 141-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06565520, a NA study of Patellofemoral Pain Syndrome, is actively recruiting participants, sponsored by University of Nevada, Las Vegas.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study sought to investigate whether modulation of cortical excitability of the gluteal musculature, via tDCS paired with exercise, will reduce the amount the knee caves in during functional tasks in individuals with PFP. The objective is the explore if having tDCS target the area of the brain controlling hip muscles, when paired with exercise, will be more effective in reducing the amount the knee caves in for individuals with PFP versus those who receive exercise alone as their treatment. The aim is to contribute our findings to the growing knowledge in this area in order to help establish the possibility, and feasibility, of its use in clinical settings to strengthen traditional treatments for this patient population.

Interventions

  • DEVICE transcranial direct current stimulator

Study Locations (1)

Nevada

  • University of Nevada, Las Vegas - Las Vegas

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-04-24
Est. Completion 2025-04-21
Phase NA
University of Nevada, Las Vegas

52 total trials

What NCT06565520 shows while recruiting

NCT06565520 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 141-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (65% lower).

The record links to 1 condition, with Patellofemoral Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which transcranial direct current stimulator is the first listed.

NCT06565520 reports a single indexed study location in Nevada.

Frequently Asked Questions

What is clinical trial NCT06565520 about?

NCT06565520 is a clinical study titled "Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain". This study sought to investigate whether modulation of cortical excitability of the gluteal musculature, via tDCS paired with exercise, will reduce the amount the knee caves in during functional tasks in individuals with PFP. The objective is the explore if having tDCS target the area of the brain c...

What is the current status of trial NCT06565520?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-24. Estimated completion is 2025-04-21.

What conditions does trial NCT06565520 study?

This clinical trial studies the following conditions: Patellofemoral Pain Syndrome.

What interventions are being tested in trial NCT06565520?

The interventions under investigation include: transcranial direct current stimulator (DEVICE).

Who is sponsoring clinical trial NCT06565520?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06565520 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patellofemoral Pain Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06565520's enrollment target sits among peer trials

50 7th of 10 higher than 4 of 10 other Patellofemoral Pain Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Patellofemoral Pain Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06565520, the US trial registry maintained by the National Library of Medicine. NCT06565520 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.